Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • foxyg
    Member
    • May 2010
    • 54

    #1

    Denovo sequencing on known reference

    I remember reading a paper talking about how denovo sequencing is useful even on known reference. Because each people's genome is slightly different. I am trying to find that paper again but couldn't anymore.

    I have some exome sequencing illumina data, I am wondering if it is worth it to do denovo sequencing in this case.

    What is your take on this subject?

    Thanks
  • v_kisand
    Member
    • Jan 2009
    • 38

    #2
    I guess you mean human genome... well I work with almost exclusively with bacteria but I do not see any advantage in de novo sequencing over reference mapping. you have to be really sure that you expect substantial re-arragements in genome of interest. Which might be easily case with various strains of bacteria ... in human genomes, I am not expert on this field but I doubt...

    Originally posted by foxyg View Post
    I remember reading a paper talking about how denovo sequencing is useful even on known reference. Because each people's genome is slightly different. I am trying to find that paper again but couldn't anymore.

    I have some exome sequencing illumina data, I am wondering if it is worth it to do denovo sequencing in this case.

    What is your take on this subject?

    Thanks

    Comment

    • krobison
      Senior Member
      • Nov 2007
      • 734

      #3
      There are regions of structural variation which are not captured in the reference genome for any species.

      One approach is to first do reference mapping, then assemble what doesn't map. Similarly, localized assembly of regions you know are dodgy -- such as if a high frequency of only one side of a paired end read mapping next to that region.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      40 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...